Literature DB >> 11479744

Nomenclature for the description of human sequence variations.

J T den Dunnen1, S E Antonarakis.   

Abstract

A nomenclature system has recently been suggested for the description of changes (mutations and polymorphisms) in DNA and protein sequences. These nomenclature recommendations have now been largely accepted. However, current rules do not yet cover all types of mutations, nor do they cover more complex mutations. This document lists the existing recommendations and summarizes suggestions for the description of additional, more complex changes. Another version of this paper has been published in Hum Mut 15:7-12, 2000.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11479744     DOI: 10.1007/s004390100505

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  237 in total

1.  Gene rearrangements in the glucocerebrosidase-metaxin region giving rise to disease-causing mutations and polymorphisms. Analysis of 25 Rec NciI alleles in Gaucher disease patients.

Authors:  Anna Díaz-Font; Bru Cormand; Mariana Blanco; Néstor Chamoles; Amparo Chabás; Daniel Grinberg; Lluïsa Vilageliu
Journal:  Hum Genet       Date:  2003-02-14       Impact factor: 4.132

2.  Subgroups at high risk for ischaemic heart disease:identification and validation in 67 000 individuals from the general population.

Authors:  Ruth Frikke-Schmidt; Anne Tybjærg-Hansen; Greg Dyson; Christiane L Haase; Marianne Benn; Børge G Nordestgaard; Charles F Sing
Journal:  Int J Epidemiol       Date:  2014-10-30       Impact factor: 7.196

3.  Genetic variability of the extraneuronal monoamine transporter EMT (SLC22A3).

Authors:  Andreas Lazar; Dirk Gründemann; Reinhard Berkels; Dirk Taubert; Tim Zimmermann; Edgar Schömig
Journal:  J Hum Genet       Date:  2003-04-09       Impact factor: 3.172

4.  Cis-acting variation in the expression of a high proportion of genes in human brain.

Authors:  Nicholas J Bray; Paul R Buckland; Michael J Owen; Michael C O'Donovan
Journal:  Hum Genet       Date:  2003-05-01       Impact factor: 4.132

5.  Chromosome 18 replaced by two ring chromosomes of chromosome 18 origin.

Authors:  K Miller; B Pabst; H Ritter; P Nürnberg; R Siebert; J Schmidtke; M Arslan-Kirchner
Journal:  Hum Genet       Date:  2003-02-06       Impact factor: 4.132

6.  Molecular markers as a complementary tool in risk assessments: quantifying interspecific gene flow from triticale to spring wheat and durum wheat.

Authors:  Vanessa B Kavanagh; Melissa J Hills; Aakash Goyal; Harpinder S Randhawa; A Keith Topinka; Francois Eudes; Linda M Hall
Journal:  Transgenic Res       Date:  2013-02-07       Impact factor: 2.788

7.  Modulating action of the new polymorphism L436F detected in the GLB1 gene of a type-II GM1 gangliosidosis patient.

Authors:  Anna Caciotti; Tiziana Bardelli; John Cunningham; Alessandra D'Azzo; Enrico Zammarchi; Amelia Morrone
Journal:  Hum Genet       Date:  2003-03-19       Impact factor: 4.132

8.  Myosin-binding protein C DNA variants in domestic cats (A31P, A74T, R820W) and their association with hypertrophic cardiomyopathy.

Authors:  M Longeri; P Ferrari; P Knafelz; A Mezzelani; A Marabotti; L Milanesi; G Pertica; M Polli; P G Brambilla; M Kittleson; L A Lyons; F Porciello
Journal:  J Vet Intern Med       Date:  2013-01-17       Impact factor: 3.333

9.  Genetics can contribute to the prognosis of Brugada syndrome: a pilot model for risk stratification.

Authors:  Elena Sommariva; Carlo Pappone; Filippo Martinelli Boneschi; Chiara Di Resta; Maria Rosaria Carbone; Erika Salvi; Pasquale Vergara; Simone Sala; Daniele Cusi; Maurizio Ferrari; Sara Benedetti
Journal:  Eur J Hum Genet       Date:  2013-01-16       Impact factor: 4.246

10.  Identification of two AGTR2 mutations in male patients with non-syndromic mental retardation.

Authors:  Tero Ylisaukko-oja; Karola Rehnström; Raija Vanhala; Carola Tengström; Jaana Lähdetie; Irma Järvelä
Journal:  Hum Genet       Date:  2003-11-04       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.